Insights

Clinical Pipeline Leap Therapeutics operates as a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, notably sirexatamab and FL-501, indicating ongoing opportunities to engage in partnerships, co-development, or strategic licensing around late-stage preclinical assets and related biomarkers.

Financial Leverage Recent PIPE financing led by notable investors (Winklevoss Capital) and a treasury strategy that includes a digital asset component suggest availability of capital for strategic collaborations, co-funded trials, or milestone-driven deals with accelerated decision timelines.

Digital Asset Strategy The company has launched a digital asset treasury and crypto engagement, which opens doors for cross-industry collaborations in blockchain-enabled clinical trial data management, tokenized fundraising, or crypto-backed partnerships with healthcare tech firms.

Clinical Milestones Upcoming or recently announced presentations of pivotal clinical data (ESMO 2025 final Part B results; AACR 2025 preclinical data) create windows for timely engagement with key stakeholders around collaboration, research agreements, or joint publication opportunities.

Operational Scale With a small to mid-size team (11-50 employees) and a diversified tech stack, Leap Therapeutics may be more agile in partnership-driven deals and prefers scalable, low-overhead collaborations, offering clear roles for CROs, contract researchers, or co-development partners.

Similar companies to Leap Therapeutics

Leap Therapeutics Tech Stack

Leap Therapeutics uses 8 technology products and services including Microsoft SharePoint, Wix, WordPress, and more. Explore Leap Therapeutics's tech stack below.

Media & News

Leap Therapeutics's Email Address Formats

Leap Therapeutics uses at least 3 email formats:
Leap Therapeutics Email FormatsExamplePercentage
FLast@leaptx.comJDoe@leaptx.com
96%
Last@leaptx.comDoe@leaptx.com
3%
FirstL@leaptx.comJohnD@leaptx.com
1%

Frequently Asked Questions

What is Leap Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Leap Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Leap Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Leap Therapeutics is a publicly traded company; the company's stock symbol is LPTX.

What is Leap Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Leap Therapeutics's official website is leaptx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Leap Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2026, Leap Therapeutics's annual revenue is estimated to be $10M - $25M.

What is Leap Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Leap Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Leap Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2026, Leap Therapeutics has approximately 18 employees across 2 continents, including North America and Europe. Key team members include Chairman Of The Board: C. M., Owner: D. P. and Principal: M. C. Explore Leap Therapeutics's employee directory with LeadIQ.

What industry does Leap Therapeutics belong to?

Minus sign iconPlus sign icon
Leap Therapeutics operates in the Biotechnology Research industry.

What technology does Leap Therapeutics use?

Minus sign iconPlus sign icon
Leap Therapeutics's tech stack includes Microsoft SharePoint, Wix, WordPress, Cookiebot, Microsoft 365, Smartsheet, New Relic and Microsoft Teams.

What is Leap Therapeutics's email format?

Minus sign iconPlus sign icon
Leap Therapeutics's email format typically follows the pattern of FLast@leaptx.com. Find more Leap Therapeutics email formats with LeadIQ.
Leap Therapeutics logo

Leap Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Leap Therapeutics is a clinical-stage biotechnology company focused on developing targeted and immuno-oncology therapeutics for cancer. Headquartered in Cambridge, Massachusetts, it operates from 47 Thorndike Street, Suite B1-1, and employs 11-50 people. The company trades on NASDAQ under the ticker LPTX and maintains a website at leaptx.com. Its pipeline includes sirexatamab and FL-501, reflecting its focus on advancing cancer therapeutics through preclinical and clinical development. In 2025, Leap Therapeutics pursued private financing and reported participation in major conferences to share data from its programs, including presentations at AACR and ESMO.

Section iconCompany Overview

Phone number
Website
leaptx.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
LPTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    Leap Therapeutics's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.